Terms: = Bone cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
40 results:
1. Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
Gassner T; Chittilappilly C; Pirich T; Neuditschko B; Hackner K; Lind J; Aksoy O; Graichen U; Klee S; Herzog F; Wiesner C; Errhalt P; Pecherstorfer M; Podar K; Vallet S
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702145
[TBL] [Abstract] [Full Text] [Related]
2. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
Rey V; Tornín J; Alba-Linares JJ; Robledo C; Murillo D; Rodríguez A; Gallego B; Huergo C; Viera C; Braña A; Astudillo A; Heymann D; Szuhai K; Bovée JVMG; Fernández AF; Fraga MF; Alonso J; Rodríguez R
EBioMedicine; 2024 Apr; 102():105090. PubMed ID: 38547578
[TBL] [Abstract] [Full Text] [Related]
3. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
[TBL] [Abstract] [Full Text] [Related]
4. Bioenergetic profile and redox tone modulate in vitro osteogenesis of human dental pulp stem cells: new perspectives for bone regeneration and repair.
Agriesti F; Landini F; Tamma M; Pacelli C; Mazzoccoli C; Calice G; Ruggieri V; Capitanio G; Mori G; Piccoli C; Capitanio N
Stem Cell Res Ther; 2023 Aug; 14(1):215. PubMed ID: 37608350
[TBL] [Abstract] [Full Text] [Related]
5. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
[TBL] [Abstract] [Full Text] [Related]
6. Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast cancer bone Microenvironment.
Iuliani M; Simonetti S; Ribelli G; Napolitano A; Longo UG; Vincenzi B; Orsaria P; Denaro V; Tonini G; Santini D; Francesco P
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269621
[TBL] [Abstract] [Full Text] [Related]
7. Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGFβ1 Activation and Suppressing Immunity in bone Marrow.
Zhang C; Xu X; Trotter TN; Gowda PS; Lu Y; Suto MJ; Javed A; Murphy-Ullrich JE; Li J; Yang Y
Mol Cancer Ther; 2022 Feb; 21(2):347-358. PubMed ID: 34907087
[TBL] [Abstract] [Full Text] [Related]
8. Surgical treatment scenario for osteoblastoma of the pelvis: Long-term follow-up results.
Fiore M; Sambri A; Calamelli C; Zucchini R; Giannini C; Distefano M; Donati DM; Leithner A; Campanacci DA; De Paolis M
J Orthop Sci; 2022 Jul; 27(4):906-912. PubMed ID: 34049756
[TBL] [Abstract] [Full Text] [Related]
9. Multiscale molecular profiling of pathological bone resolves sexually dimorphic control of extracellular matrix composition.
Sharma A; Goring A; Johnson PB; Emery RJH; Hesse E; Boyde A; Olsen BR; Pitsillides AA; Oreffo ROC; Mahajan S; Clarkin CE
Dis Model Mech; 2021 Mar; 14(3):. PubMed ID: 33563616
[TBL] [Abstract] [Full Text] [Related]
10. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the bone Microenvironment at New bone Sites.
Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
[TBL] [Abstract] [Full Text] [Related]
11. European multicentre study on technical success and long-term clinical outcome of radiofrequency ablation for the treatment of spinal osteoid osteomas and osteoblastomas.
Beyer T; van Rijswijk CSP; Villagrán JM; Rehnitz C; Muto M; von Falck C; Gielen J; Thierfelder KM; Weber MA
Neuroradiology; 2019 Aug; 61(8):935-942. PubMed ID: 31161261
[TBL] [Abstract] [Full Text] [Related]
12. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
Mosebach J; Thierjung H; Schlemmer HP; Delorme S
Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
Armstrong AJ; Gupta S; Healy P; Kemeny G; Leith B; Zalutsky MR; Spritzer C; Davies C; Rothwell C; Ware K; Somarelli JA; Wood K; Ribar T; Giannakakou P; Zhang J; Gerber D; Anand M; Foo WC; Halabi S; Gregory SG; George DJ
PLoS One; 2019; 14(5):e0216934. PubMed ID: 31136607
[TBL] [Abstract] [Full Text] [Related]
14. The Endocannabinoid/Endovanilloid System in bone: From Osteoporosis to Osteosarcoma.
Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
[TBL] [Abstract] [Full Text] [Related]
15. Osteoblastomatosis: an unusual diagnosis and treatment.
Quílez-Caballero E; Martel-Villagran J; Bueno-Horcajadas ÁL; López-Brasal L; Díaz-Candamio MJ
Skeletal Radiol; 2018 Aug; 47(8):1183-1189. PubMed ID: 29450575
[TBL] [Abstract] [Full Text] [Related]
16. Neoadjuvant denosumab for the treatment of a sacral osteoblastoma.
Reynolds JJ; Rothenfluh DA; Athanasou N; Wilson S; Kieser DC
Eur Spine J; 2018 Jul; 27(Suppl 3):446-452. PubMed ID: 29356985
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic reliability of pretreatment biopsy in malignant nasoethmoidal tumors: A retrospective study of 77 cases.
Schreiber A; Rampinelli V; Ferrari M; Mattavelli D; Farina D; Battocchio S; Nicolai P
Laryngoscope; 2018 Aug; 128(8):1772-1777. PubMed ID: 29314070
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative Embolization and Complete Tumoral Resection of a Cervical Aggressive Epithelioid Osteoblastoma.
Schur S; Camlioglu E; Jung S; Powell T; Gutman G; Golan J
World Neurosurg; 2017 Oct; 106():1051.e1-1051.e4. PubMed ID: 28710051
[TBL] [Abstract] [Full Text] [Related]
19. Percutaneous radiofrequency ablation for spinal osteoid osteoma and osteoblastoma.
Wang B; Han SB; Jiang L; Yuan HS; Liu C; Zhu B; Liu ZJ; Liu XG
Eur Spine J; 2017 Jul; 26(7):1884-1892. PubMed ID: 28391383
[TBL] [Abstract] [Full Text] [Related]
20. bone Disease in Multiple Myeloma.
Eda H; Santo L; David Roodman G; Raje N
Cancer Treat Res; 2016; 169():251-270. PubMed ID: 27696267
[TBL] [Abstract] [Full Text] [Related]
[Next]
